Hospac Pharmacy

Hospac Pharmacy To inform people about new stock and also to inform pharmacists, clinic directors and other drug sellers about drugs available for wholesales.

Key Steps to Manage Metabolic Syndrome: Adopting a Healthy Lifestyle and Medical Care RoutineImplementing the following ...
23/08/2026

Key Steps to Manage Metabolic Syndrome: Adopting a Healthy Lifestyle and Medical Care Routine

Implementing the following measures is crucial for managing metabolic syndrome: consuming a balanced diet rich in fruits, vegetables, and whole grains, engaging in regular physical activity, refraining from smoking, and controlling blood pressure, cholesterol, and blood sugar levels.

Opt for fish and skinless poultry instead of processed meats.

Restrict saturated and trans fats commonly found in red meat, fried foods, and whole-milk dairy products; instead, utilize healthy oils like olive or canola oil.

Limit additional dietary components: reduce salt intake, avoid added sugars (including those present in soft drinks), and restrict refined grains.

Daily Habits and Medical Care

Abstain from smoking: quit smoking and avoid secondhand smoke to safeguard your blood vessel walls.

Manage underlying conditions: maintain strict control over high blood pressure, diabetes, and high cholesterol.

Adhere to prescribed medications: if lifestyle modifications are insufficient, your physician may recommend specific medications, such as statins, to manage cholesterol or blood pressure levels.

Active Living and Weight Management

Engage in regular physical activity: aim for 30 to 45 minutes of moderate-intensity exercise, such as brisk walking or cycling, at least 4 to 5 days a week.

Achieve a healthy weight: shedding even a small amount of excess weight can significantly lower your blood pressure and bad cholesterol levels.

Happy Sunday to you all.

His Royal Highness Alh Abdulkareem Obeitor, the Odeyiani Anebira- Lokoja on behalf of the entire Ebira Community in Loko...
28/05/2026

His Royal Highness Alh Abdulkareem Obeitor, the Odeyiani Anebira- Lokoja on behalf of the entire Ebira Community in Lokoja and environs heartily felicitates with His Excellency Alh. Usman Ahmed Ododo ,Executive Governor of Kogi State.
Her Excellency Hajia Sefinat Usman Ododo, First Lady of Kogi state.
Hon. Abdullahi Bello, Honourable Commissioner for Local Government & Chieftaincy Affairs.
His Royal Majesty, Alh- Dr Ahmed Tijani Muhammed Anaje, the Ohinoyi of Ebiraland.
His Royal Highness, Alh. Ibrahim Gambo Muhammed Kabir, the Maigari of Lokoja.
The Ohireba Anebira -Lokoja.
The Onoba- Obanyin Anebira -Lokoja.
The Ebira Traditional council Members comprising all the Onobas and Daudus.
The entire Ebira community in Lokoja and environ i.e Ebira Peoples Association, Ebira Youth Congress, Ebira Vonya Women Association and all other Associations on the ocassion of 2026 Sallah Celebrations.

BARKA EID ADHA.
ODEYANI ANEBIRA MEDIA ORGANISATION.

*In Defence Of Fairness: Rethinking The Narrative Around Dr. Mustapha Abdullahi*In today’s Nigeria, public perception ca...
16/05/2026

*In Defence Of Fairness: Rethinking The Narrative Around Dr. Mustapha Abdullahi*

In today’s Nigeria, public perception can change within minutes. All it takes is a headline, a trending topic, or a viral social media post. Once the name of a public official becomes associated with agencies like the EFCC, many people immediately rush to conclusions long before facts are properly established. Unfortunately, that appears to be the reality surrounding the recent reports involving Dr. Mustapha Abdullahi, Director-General of the Energy Commission of Nigeria.

Over the last few days, different media platforms circulated reports suggesting that the Energy Commission boss had been arrested over alleged financial misconduct. Almost instantly, the story spread across blogs, WhatsApp groups, Facebook timelines, and political discussions, with many already forming opinions before any official clarification was heard directly from either the EFCC or Dr. Abdullahi himself.

However, beyond the sensational headlines and social media reactions lies a more important issue that deserves thoughtful reflection. Was this truly the kind of extraordinary situation it was made to appear, or was a routine institutional process exaggerated into a public spectacle?

For many people familiar with government institutions and public service operations, interactions with oversight agencies such as the EFCC and ICPC are not unusual. Public officers, especially those occupying strategic positions within ministries, departments, and agencies, are regularly reminded about the importance of accountability, transparency, and proper record keeping. During trainings, orientations, and compliance sessions, officials are often cautioned that anti-corruption agencies may request clarifications, documents, or explanations at any time in the course of their duties.

This is considered part of institutional procedure, not an automatic declaration of guilt.

In fact, many civil servants and public administrators understand that such invitations can arise from procurement reviews, project assessments, budget clarifications, or administrative oversight processes. That is why many observers found the dramatic tone of the media reports surrounding Dr. Abdullahi both premature and unnecessary.

Ordinarily, when a public official repeatedly ignores invitations from investigative agencies or attempts to evade questioning, the situation escalates publicly. In many cases, agencies issue formal notices, declare individuals wanted, or release official statements indicating non-compliance. Yet, before the reports about Dr. Abdullahi circulated across the media space, there had been no such indication publicly released by the EFCC.

Instead, subsequent clarifications suggested that the DG honoured the invitation extended to him and cooperated with investigators. That distinction is important because there is a clear difference between a public servant responding to institutional inquiries and the dramatic image of criminal apprehension many headlines attempted to create.

Unfortunately, in the modern media environment, nuance is often sacrificed for attention-grabbing narratives. Once emotionally charged words such as “fraud,” “arrest,” or “EFCC investigation” appear in circulation, public judgment tends to move faster than due process.

Perhaps the most revealing aspect of the entire situation has been the public reaction itself. Before any formal conclusion, before any judicial pronouncement, and before investigations had even fully unfolded, countless individuals immediately came forward to defend Dr. Abdullahi’s character and contributions.

That reaction did not happen by accident.

Over time, Dr. Mustapha Abdullahi has built a reputation that extends beyond his official title. Across communities, particularly among young people and grassroots beneficiaries, his name has increasingly become associated with empowerment initiatives, educational support, humanitarian interventions, and developmental outreach. Many people who have encountered his philanthropic activities see him as someone who has consistently invested in human capital and community development.

In reality, not every public official enjoys that kind of goodwill from ordinary citizens. There are individuals whose names, once linked with allegations, would instantly attract public condemnation without hesitation. Yet in this case, many people instinctively paused and asked questions before rushing to judgment. That response alone says something significant about the relationship he has built with the public over time.

This situation also highlights a growing concern within Nigeria’s media and political landscape: the increasing tendency toward trial by media. Allegations are rapidly transformed into convictions in the minds of the public, while investigations are treated as final proof of wrongdoing rather than part of a legal process.

No society can sustain justice when accusations alone become enough to permanently damage reputations. Accountability is essential in every democracy, and public officials must never be placed above scrutiny. Institutions like the EFCC and ICPC have important responsibilities and should be allowed to perform their duties without interference.

At the same time, fairness must remain part of the conversation.

There must be room for due process, context, and balance. There must be a difference between investigation and conviction, between invitation and arrest, and between public suspicion and legally established facts. Without those distinctions, society risks replacing justice with assumption.

Supporters of Dr. Abdullahi believe the current narrative ignores years of visible impact and public service. To them, reducing an individual’s entire reputation to unverified headlines without allowing facts to fully emerge is both unfair and dangerous. They argue that public figures who become increasingly influential and widely accepted often attract political hostility, media attacks, and reputational battles designed to weaken public confidence in them.

Whether one agrees with that perspective or not, one principle remains undeniable: every individual deserves fairness.

At this point, the most responsible approach is not blind defence and certainly not blind condemnation. Institutions should continue their work professionally and transparently, while the public exercises patience and restraint until facts are properly established.

The conversation surrounding Dr. Mustapha Abdullahi is ultimately bigger than one man. It reflects the larger challenge of balancing accountability with fairness in a society increasingly driven by viral headlines and emotional reactions.

In the end, reputations should not be destroyed by speculation alone, and years of visible service should not be erased overnight by narratives that remain subject to investigation and clarification

Pharm Agoyi Emmanuel

16/03/2026
05/03/2026

Where are you from.can we be friends?

02/03/2026

I want to be your friend. Hi. Send your whatsapp no.

The dose makes the poisonThe principle relies on the finding that all chemicals—even water and oxygen—can be toxic if to...
12/07/2025

The dose makes the poison

The principle relies on the finding that all chemicals—even water and oxygen—can be toxic if too much is eaten, drunk, or absorbed.
This finding also provides the basis for public health standards, which specify maximum acceptable concentrations of various contaminants in food, public drinking water, and the environment.

The idea also describes the phenomenon in which a poisonous substance, such as digitalis, can be medicinal (digoxin) in small, controlled doses.

11/07/2020

These tests are expensive, and manufacturers pass on some of these costs to the consumer.

Second, while a brand-name drug is only sold by one manufacturer, several companies will usually sell the same generic drug, which leads to competition in the marketplace and lower costs for consumers.

How much cheaper are generic drugs?

Generic medications typically cost about 80% to 85% less than the same brand-name drug. According to 1 study, generic drugs saved the U.S. healthcare system $1.67 trillion from 2007 to 2016.

How do I tell them apart?

If you’re worried about picking up the wrong prescription, you can relax. Telling the difference between a generic and a brand-name drug isn’t too hard.

Due to trademark laws, generic and brand-name medications cannot look the same. In many cases, the name of the generic drug will be the same as the active ingredient, such as omeprazole (the generic version of Prilosec, a medication used to treat gastroesophageal reflux disease, or GERD).

The generic and brand versions may differ on:

Shape

Color

Packaging

Flavorings

Inactive ingredients

However, these differences don’t mean a generic drug is any less effective or works differently than a brand-name one.

Don't miss out on savings!

Get the best ways to save on your prescriptions delivered to your inbox.

By signing up, I agree to GoodRx's terms of service and privacy policy.

Are generic drugs safe?

Yes. Generic drugs are heavily regulated and go through a rigorous review process before they’re approved.

The FDA tests them to make sure they offer the same benefits as brand-name medications and that any different ingredients used in the generic drug are safe. They will also test how sturdy the drug’s container is, how long an unused drug will last before it breaks down, and whether the drug’s manufacturer can consistently and correctly make the drug. The FDA will only approve the drug if it meets all these requirements for safety.

Address

Okonu Complex, Opp Specialist Hospital
Lokoja

Telephone

08032903593

Website

Alerts

Be the first to know and let us send you an email when Hospac Pharmacy posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Hospac Pharmacy:

Shortcuts

Share